Healthcare Services Group director acquires 367 units

The DSUs are to be settled in common stock 90 days after Laura K. Grant separates from board service, with further deferral permitted under Code Section 409A.

Rhea-AI Filing Summary

Healthcare Services Group Inc. (HCSG) director Laura K. Grant acquired 367 fully vested deferred stock units (DSUs) on September 30, 2026, in lieu of cash fees for board and committee service. The units were calculated using a closing stock price of $20.45 per share on the date the fees would otherwise have been paid. Her reported post-transaction position was 18,681 shares represented by DSUs, including 1,969 unvested and 16,712 vested DSUs. The DSUs are to be settled in common stock 90 days after her board service ends, with further deferral permitted under Code Section 409A.

Insider Trade Summary 10b5-1

Grant/Award: 367 shares

Grant/Award 1 txn

Insider Grant Laura K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	367	$20.45	$8K

Holdings After Transaction: Common Stock — 18,681 shares (Direct)

Footnotes (2)

1. F1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Amended Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to the director's fees earned in 2026 in compliance with the issuer's black-out period guidelines. The number of shares represents the quotient of the amount of such fees divided by the issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock ninety days following separation of service from the Board. The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A.
2. F2. Amount represents 1,969 unvested DSUs and 16,712 vested DSUs.

Key Figures

DSUs acquired: 367 DSUs Closing stock price used in calculation: $20.45 per share Post-transaction position: 18,681 shares represented by DSUs +3 more

6 metrics

DSUs acquired 367 DSUs September 30, 2026

Closing stock price used in calculation $20.45 per share On the date the fees would otherwise have been paid

Post-transaction position 18,681 shares represented by DSUs Reported after the transaction

Unvested DSUs 1,969 DSUs Included in the reported post-transaction position

Vested DSUs 16,712 DSUs Included in the reported post-transaction position

Settlement period 90 days Following separation of service from the board

Key Terms

Deferred Stock Units, 2020 Amended Omnibus Incentive Plan, Code Section 409A

3 terms

Deferred Stock Units technical

"fully vested shares of Deferred Stock Units ("DSUs")"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

2020 Amended Omnibus Incentive Plan financial

"under the Issuer's 2020 Amended Omnibus Incentive Plan"

Code Section 409A regulatory

"pursuant to the rules of Code Section 409A"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DSUs did HCSG director Laura K. Grant acquire?

Laura K. Grant acquired 367 fully vested DSUs on September 30, 2026. The units were calculated using a closing stock price of $20.45 per share on the date the related fees would otherwise have been paid.

How were Laura K. Grant’s HCSG director fees converted into DSUs?

Grant elected in 2025 to receive fully vested DSUs instead of cash fees for board and committee service, and the election applied to fees earned in 2026. The number of units was calculated by dividing the fees by the issuer’s closing stock price on the date the fees would otherwise have been paid, then rounding up to the nearest whole share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 04:06 PM Accepted by SEC EDGAR 10/01/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grant Laura K

(Last) (First) (Middle)

3220 TILLMAN DRIVE

SUITE 300

(Street)

BENSALEM PENNSYLVANIA 19020

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2026		A		367	A	$20.45(1)	18,681(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Amended Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to the director's fees earned in 2026 in compliance with the issuer's black-out period guidelines. The number of shares represents the quotient of the amount of such fees divided by the issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock ninety days following separation of service from the Board. The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A.

2. Amount represents 1,969 unvested DSUs and 16,712 vested DSUs.

Remarks:

	Michael Harrity, by Power of Attorney	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)